Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children

Inclusion Criteria: * Signature of informed consent from the parent / legal guardian of the patient. * Patients with mild-moderate atopic dermatitis (SCORAD \>20). * Age between 6 months and 3 years old, both inclusive (36 months). * Patients using topical corticosteroids. * Diagnosis of atopic dermatitis. Exclusion Criteria: * In treatment with phototherapy for atopic dermatitis in the previous 2 months * In treatment with systemic corticosteroids in the previous month. * In treatment with immunosuppressants or cytostatics in the previous 2 months. * Those who have received probiotic treatment in the previous month. * Those who have been treated with systemic antibiotics in the previous two weeks. * Patients with axillary or oral temperature \> 37.5ºC; or rectal or otic temperature \> 38ºC. * Patients with severe allergic diseases. * Patients with pathologies related to immunodeficiency or cancer processes. * Patients with other dermatological pathologies that may make it difficult to assess atopic dermatitis or require the continued use of topical corticosteroids. * Patients in whom any of the products under study is contraindicated as established in their technical specifications. * Patients who have participated in drug research studies in the previous 3 months